Coherus BioSciences Announces New Employment Inducement Grants

Coherus BioSciences (Nasdaq: CHRS) announced the grant of stock options for an aggregate of 234,000 shares to 22 new employees, effective August 24, 2022.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Very Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Coherus BioSciences (Nasdaq: CHRS) announced the grant of stock options for an aggregate of 234,000 shares to 22 new employees, effective August 24, 2022. The options have a per-share exercise price of $12.90, matching the closing trading price on the grant date. This action is part of the Company’s 2016 Employment Commencement Incentive Plan aimed at attracting new talent.

Positive

Granting stock options shows Coherus's commitment to attracting new talent.
Stock options offered at market price of $12.90 may incentivize employee performance.

Negative

None.

Argus Session date unavailable

-1.64% session move Open Argus

Details

News Market Reaction – CHRS

The recorded move for CHRS in the trading session of this news was -1.64%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/29/2022 - 08:49 PM

REDWOOD CITY, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective August 24, 2022, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 234,000 shares of the common stock of the Company to 22 newly hired employees with a per share exercise price of $12.90, the closing trading price on the grant date.

The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.

Coherus BioSciences Contact Information:

IR Contact
Marek Ciszewski
Coherus BioSciences, Inc.
IR@coherus.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock options were granted by Coherus BioSciences?

Coherus BioSciences granted options to purchase 234,000 shares to 22 new employees.

What is the exercise price for the stock options granted by Coherus?

The exercise price for the stock options is $12.90 per share.

When did Coherus BioSciences announce the stock option grant?

The stock option grant was announced on August 29, 2022.

Which plan facilitated the stock option grant by Coherus BioSciences?

The stock option grant was facilitated by the Coherus BioSciences 2016 Employment Commencement Incentive Plan.

Keep reading

Trending in the feed

PCRX

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies Open the live feed